Middle Eastern Penny Stocks To Watch In March 2026

ALMODAWAT +1.27%

ALMODAWAT

9594.SA

4.00

+1.27%

Gulf markets have recently experienced a downturn, with geopolitical tensions in the Middle East prompting investors to exercise caution. Despite these challenges, the concept of penny stocks remains appealing to some investors due to their potential for growth and affordability. While the term "penny stocks" may seem outdated, it still signifies smaller or emerging companies that could offer substantial opportunities when backed by strong financials.

Top 10 Penny Stocks In The Middle East

Name Share Price Market Cap Rewards & Risks
Al-Modawat Specialized Medical (SASE:9594) SAR4.00 SAR284.77M ✅ 2 ⚠️ 4 View Analysis >
ADNOC Gas (ADX:ADNOCGAS) AED3.25 AED248.56B ✅ 5 ⚠️ 1 View Analysis >
Thob Al Aseel (SASE:4012) SAR3.57 SAR1.43B ✅ 2 ⚠️ 1 View Analysis >
Alpha Data PJSC (ADX:ALPHADATA) AED1.46 AED1.49B ✅ 2 ⚠️ 1 View Analysis >
Al Wathba National Insurance Company PJSC (ADX:AWNIC) AED3.04 AED629.28M ✅ 2 ⚠️ 2 View Analysis >
Dubai Investments PJSC (DFM:DIC) AED3.83 AED15.99B ✅ 2 ⚠️ 4 View Analysis >
Al Waha Capital PJSC (ADX:WAHA) AED1.68 AED3.19B ✅ 2 ⚠️ 2 View Analysis >
Abu Dhabi National Hotels Company PJSC (ADX:ADNH) AED0.398 AED4.96B ✅ 1 ⚠️ 3 View Analysis >
Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED1.05 AED650.83M ✅ 2 ⚠️ 2 View Analysis >
Tgi Infrastructures (TASE:TGI) ₪2.551 ₪194.2M ✅ 2 ⚠️ 2 View Analysis >

Here's a peek at a few of the choices from the screener.

Yesil Yatirim Holding Anonim Sirketi (IBSE:YESIL)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Yesil Yatirim Holding Anonim Sirketi specializes in technical planning, programming, budgeting, project planning, and financial organization with a market cap of TRY1.12 billion.

Operations: Yesil Yatirim Holding Anonim Sirketi has not reported any specific revenue segments.

Market Cap: TRY1.12B

Yesil Yatirim Holding Anonim Sirketi, with a market cap of TRY1.12 billion, is pre-revenue and unprofitable, reporting negative sales of TRY2.57 million for 2025. Despite being debt-free and having short-term assets exceeding liabilities by a significant margin (TRY458.4M vs TRY4.3M), the company faces challenges with less than a year of cash runway and increasing losses over the past five years at 15% annually. Its share price remains highly volatile, though shareholders have not been diluted recently. The management's tenure data is insufficient to assess experience levels comprehensively.

    IBSE:YESIL Debt to Equity History and Analysis as at Mar 2026
    IBSE:YESIL Debt to Equity History and Analysis as at Mar 2026

    Fitaihi Holding Group (SASE:4180)

    Simply Wall St Financial Health Rating: ★★★★☆☆

    Overview: Fitaihi Holding Group operates in Saudi Arabia, offering gold, jewelry, and luxury products with a market cap of SAR698.50 million.

    Operations: The company generates revenue of SAR58.79 million from its operations within Saudi Arabia.

    Market Cap: SAR698.5M

    Fitaihi Holding Group, with a market cap of SAR698.50 million, reported a decline in sales to SAR58.79 million for 2025 from SAR67.94 million the previous year, and net income dropped to SAR4.05 million from SAR14.52 million. Despite high-quality earnings and adequate coverage of interest payments, the company faces challenges with negative operating cash flow and increased debt-to-equity ratio over five years to 0.3%. Short-term assets (SAR108.8M) comfortably cover both short-term (SAR11.1M) and long-term liabilities (SAR3.6M). However, declining profit margins and low return on equity highlight ongoing financial pressures amidst stable weekly volatility.

      SASE:4180 Debt to Equity History and Analysis as at Mar 2026
      SASE:4180 Debt to Equity History and Analysis as at Mar 2026

      Al-Modawat Specialized Medical (SASE:9594)

      Simply Wall St Financial Health Rating: ★★★★☆☆

      Overview: Al-Modawat Specialized Medical Company operates a general hospital in the southern Aseer region of Saudi Arabia, with a market cap of SAR284.77 million.

      Operations: The company generates revenue primarily from Medical Services, amounting to SAR111.43 million, and Pharmaceutical Products, contributing SAR5.69 million.

      Market Cap: SAR284.77M

      Al-Modawat Specialized Medical Company, with a market cap of SAR284.77 million, has demonstrated strong financial performance. Its earnings surged by 212.4% in the past year, surpassing the healthcare industry average growth of 14.9%. The company's net profit margin improved significantly to 15.6% from 8% last year, and it maintains a high return on equity at 21.5%. Despite its satisfactory net debt to equity ratio of 16.4%, challenges remain as dividends are not well covered by free cash flows and operating cash flow does not adequately cover debt obligations, indicating potential liquidity concerns amidst volatile share prices.

        SASE:9594 Financial Position Analysis as at Mar 2026
        SASE:9594 Financial Position Analysis as at Mar 2026

        Where To Now?

        • Dive into all 81 of the Middle Eastern Penny Stocks we have identified here.
        • Searching for a Fresh Perspective? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

        This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.